Double-blind cross-over study of Demazin Chronosules capsules and Eskornade spansules.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002744:Chlorpheniramine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D014663:Nasal Decongestants / Q000009:adverse effects / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012123:Pulmonary Ventilation / Q000187:drug effects; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012220:Rhinitis / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D004338:Drug Combinations; D014663:Nasal Decongestants; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; C001941:chlorpheniramine, ephedrine drug combination; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; C001942:Eskornade Spansules; D004809:Ephedrine